See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100397_2022_Ayala_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001100397, Ayala Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 43,257,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,354,000 |
| 2 | PropertyPlantAndEquipmentNet | 118,000 |
| 3 | remainder_Assets | 51,000 |
| 4 | LiabilitiesCurrent | 7,880,000 |
| 5 | LiabilitiesNoncurrent | 12,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,373,349 |
| 9 | ResearchAndDevelopmentExpense | 9,955,016 |
| 10 | remainder_Expenses | 70,123 |
| 11 | remainder_Revenues | 1,988,782 |
| 12 | remainder_NetIncome | 784,680 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 46,780,000 |
| 1 | Liabilities | 7,892,000 |
| 2 | Expenses | 21,398,488 |
| 3 | Revenues | 1,988,782 |
| 4 | StockholdersEquity | 38,888,000 |
| 5 | NetIncome | -18,625,026 |
| 6 | ComprehensiveNetIncome | -18,625,026 |
| 7 | BaseVar | 39,421,975 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.42 |
| 9 | EconomicCapitalRatio | 3.30 |
Edgar->Model Mapping
Feature Distribution
Change over Time
